Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.310
-0.080 (-5.76%)
At close: Apr 1, 2025, 4:00 PM
1.320
+0.009 (0.73%)
After-hours: Apr 1, 2025, 4:34 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $2.50 million as of April 1, 2025. Its market cap has decreased by -57.92% in one year.
Market Cap
2.50M
Enterprise Value
276.45K
1-Year Change
-57.92%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $11.31B to $2.50M, a decrease of -99.98%. That is a compound annual growth rate of -86.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 2.65M | -27.26% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.74% |
| Dec 31, 2020 | 11.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.30B |
| UnitedHealth Group | 479.14B |
| Johnson & Johnson | 400.61B |
| AbbVie | 370.78B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 229.16B |
| AstraZeneca | 229.16B |
| Merck & Co. | 225.28B |